However, further experiments and investigations focused on additional clinical samples are essential to understand the seemingly distinct BACH2–PRDM1 mediated regulatory mechanisms in DLBCL and CLL. The gene discussed is BACH2; the disease is B-cell chronic lymphocytic leukemia.